Letrazole Femara CAS:112809-51-5
Inquiry
Post Date: | Aug 31,2016 |
Expiry Date: | Feb 27,2017 |
Detailed Description: |
Cas No. :112809-51-5
Quantity: 0.01Kilograms Price:1.25 USD Kilograms Letrazole Femara CAS:112809-51-5 E:steroidcn at ycgmp.com Sky:live:bella881030 Letrozo Alias:Letrazo; Letrozo Fe-mara CAS No: 112809-51-5 Molecular formula: C17H11N5 Molecular weight: 285.3 Appearance: White power Assay: 99% Minimum order: 10g Quality standard: USP32 Payment:Western Union and Money Gram Delivery:Within 24hours After Your Payment Detail: Femara is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women. Femara is intended for use only by women who are no longer of childbearing age. Possible candidates must have already ceased to menstruate. It is often used in patients who have already undergone other cancer treatments, such as radiation, chemotherapy, and used other cancer drugs, like tamoxifen. This nonsteroidal aromatase inhibitor may help prevent any remaining cancer cells from spreading. Femara is used for the treatment of post-menopause breast cancer. Femara is a powerful Aromatase Inhibitor that was developed to fight breast cancer. For athletes and bodybuilders, it is a drug used to combat the estrogenic side effects of anabolic steroids water-retention, acne and gynocomastia. It will also raise testosterone levels because of the lowered estrogen in the body. Side effects from include a lowered sex drive and continuous use can lead to lowered lipid function and an impaired immune system. |
CAS Registry Number: | 112809-51-5 |
Synonyms: | ;4,4'-(1h-1,2,4-Triazol-1-Ylmethylene)Bisbenzonitrile;Lelrozol;4,4'-(1h-1,2,4-Triazol-1-Ylmethylene) Bis-Benzonitrile;Femara;Letrozol;Letrazole; |
Molecular Formula: | C17H11N5 |
Molecular Weight: | 285.31 |
Molecular Structure: |
Company: | Gongchuang Technology Co.,Ltd [ China ] |
Contact: | Bella Lee |
Tel: | 86-27-50755950 |
Fax: | |
Email: | steroidcn@ycgmp.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.